Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
80,495,416
-
Share change
-
+80,495,416
-
Total reported value
-
$175,520,274
-
Put/Call ratio
-
123%
-
Price per share
-
$2.18
-
Number of holders
-
73
-
Value change
-
+$175,520,274
-
Number of buys
-
73
Institutional Holders of AVALO THERAPEUTICS INC - COM (AVTX) as of Q3 2021
As of 30 Sep 2021,
AVALO THERAPEUTICS INC - COM (AVTX) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,495,416 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Integral Health Asset Management, LLC, Opaleye Management Inc., GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
73
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.